Thrombosis and Haemostasis 2012-05-01

Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.

Rojin Park, Lifang Ping, Jaewoo Song, Sung-Yu Hong, Tae-Youn Choi, Jong-Rak Choi, Oleg V Gorkun, Susan T Lord

Index: Thromb. Haemost. 107(5) , 875-83, (2012)

Full Text: HTML

Abstract

The fibrinogen γ-module has several important sites relating to fibrinogen function, which include the high affinity calcium binding site, hole 'a' that binds with knob 'A', and the D:D interface. Residue γAla341, which is located in the vicinity of these sites, is altered in three variant fibrinogens: fibrinogen Seoul (γAla341Asp), Tolaga Bay (γAla341Val), and Lyon III (γAla341Thr). In order to investigate the impaired polymerisation of fibrinogens γAla341Asp and γAla341Val to understand the role of γAla341 in fibrin polymerisation and fibrinogen synthesis, we have expressed γAla341Asp and γAla341Val in Chinese hamster ovary (CHO) cells, purified these fibrinogens from the culture media and performed biochemical tests to elucidate their function. Expression in CHO cells was similar for these variants. For both variants the kinetics of thrombin-catalysed FpA release was not different from normal fibrinogen, while FpB release was slower than that of normal. Thrombin-catalysed polymerisation of both variants was dependent on the calcium concentration. At physiologic calcium (1 mM) the variants showed impaired polymerisation with a longer lag period and a slower Vmax than normal fibrinogen. Scanning electron micrographs showed the clots were less organised than normal, having thicker and more twisted fibers, and larger pores. Analysis by SDS-PAGE showed that factor XIIIa-catalysed γ and α chain cross-linking was delayed, and plasmin-catalysed lysis was not reduced by the presence of 5 mM calcium or 5 mM GPRP (Gly-Pro-Arg-Pro). Our data indicate that fibrinogen residue γAla341 is important for the proper conformation of the γ-module, maintaining calcium-binding site and 'A-a' interactions.


Related Compounds

Related Articles:

Thromboprophylaxis in patients receiving chemotherapy.

2012-05-10

[N. Engl. J. Med. 366(19) , 1839; author reply 1839-40, (2012)]

Routine heparin for patients with cancer? One answer, more questions.

2012-02-16

[N. Engl. J. Med. 366(7) , 661-2, (2012)]

Congenital dysfibrinogenemia Aα Gly13Glu associated with bleeding during pregnancy.

2011-03-01

[Thromb. Res. 127(3) , 277-8, (2011)]

Thrombogenicity of a new injectable biocompatible elastomer for aneurysm exclusion, compared to expanded polytetrafluoroethylene in a human ex vivo model.

2012-06-01

[Eur. J. Vasc. Endovasc. Surg. 43(6) , 675-80, (2012)]

Novel aspects of fibrin(ogen) fragments during inflammation.

2011-01-01

[Mol. Med. 17(5-6) , 568-73, (2011)]

More Articles...